During the past decade, Quantum Laboratories conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 11 clinical trials were completed, i.e. on average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Quantum Laboratories" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "Alzheon Inc." with 1 trials sponsored, "AstraZeneca" with 1 trials sponsored and "Avid Radiopharmaceuticals" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quantum Laboratories" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Grifols Biologicals, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Quantum Laboratories" are "Alzheimer's Disease" (9 trials), "Alzheimer Disease" (2 trials), "Early Alzheimer's Disease" (2 trials), "Alzheimers Disease" (1 trials) and "Dementia of Alzheimer's Type" (1 trials). Many other conditions were trialed in "Quantum Laboratories" in a lesser frequency.

Most popular intervention types in "Quantum Laboratories" are "Drug" (17 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Solanezumab" (2 trials), "Aducanumab" (1 trials), "Albumin 20%" (1 trials) and "Albumin 5%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quantum Laboratories" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Quantum Laboratories". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Quantum Laboratories, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Quantum Laboratories, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".